Ethnic and racial differences in diabetes care: The Insulin Resistance Atherosclerosis Study.

OBJECTIVE Diabetes and its complications disproportionately affect African Americans and Hispanics. Complications could be prevented with appropriate medical care. We compared five processes of care and three outcomes of care among African Americans, Hispanics, and non-Hispanic whites. RESEARCH DESIGN AND METHODS We used data from the Insulin Resistance Atherosclerosis Study (1993-1998) of participants with known diabetes. African Americans and Hispanics were compared with non-Hispanic whites from the same region. Five process measures (treatment of diabetes, hypertension, hyperlipidemia, albuminuria, and coronary artery disease) and three outcome measures (control of diabetes, hypertension, and hyperlipidemia) were evaluated. RESULTS Comparison groups were similar in baseline characteristics. African Americans and Hispanics were equally likely as their non-Hispanic white comparison group to receive treatment for diabetes, hypertension, hyperlipidemia, albuminuria, and coronary artery disease, although treatment rates for hyperlipidemia and albuminuria were poor for all groups. African Americans were more likely to have poorly controlled diabetes (HbA(1c) >8.0%: OR 2.23, 95% CI 1.26-3.94). Both African American and Hispanics were significantly more likely to have borderline or poorly controlled hypertension than non-Hispanic whites (blood pressure >130-140/85-90 or >140/90 mmHg: African American/non-Hispanic white OR 3.22, 95% CI 1.57-6.59; Hispanic/non-Hispanic white 3.14, 1.35-7.3). CONCLUSIONS The rates of treatment for diabetes and associated comorbidities are similar across all three ethnic groups. Few individuals in any ethnic group received treatment for hyperlipidemia and albuminuria. Ethnic disparities exist in control of diabetes and hypertension. Programs should be tested to improve overall quality of care and eliminate these disparities.

[1]  Jennifer Y. Liu,et al.  Ethnic disparities in diabetic complications in an insured population. , 2002, JAMA.

[2]  B. Smedley,et al.  Unequal Treatment: Con-fronting Racial and Ethnic Disparities in Health Care , 2002 .

[3]  D. Singer,et al.  The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus. , 2001, The American journal of medicine.

[4]  T. Liesegang.  Racial differences in the response to drugs—pointers to genetic differences. Wood AJJ.∗∗ N Engl J Med 2001;344:1393–1396. , 2001 .

[5]  C. Yancy,et al.  Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure. , 2001, New England Journal of Medicine.

[6]  M. Domanski,et al.  Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction. , 2001, The New England journal of medicine.

[7]  A. Wood.  Racial differences in the response to drugs--pointers to genetic differences. , 2001, The New England journal of medicine.

[8]  M. Harris,et al.  Racial and ethnic differences in health care access and health outcomes for adults with type 2 diabetes. , 2001, Diabetes care.

[9]  R. Kim,et al.  Molecular basis of ethnic differences in drug disposition and response. , 2001, Annual review of pharmacology and toxicology.

[10]  R. Holman,et al.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study , 2000, BMJ : British Medical Journal.

[11]  John S Yudkin,et al.  Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study , 2000, BMJ : British Medical Journal.

[12]  P. Peloso,et al.  An evidence-based review of ACE inhibitors in incipient diabetic nephropathy. , 2000, The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique.

[13]  C. Sylvén,et al.  Angiotensin‐II type 1 receptor gene polymorphism and long‐term survival in patients with idiopathic congestive heart failure , 1999, European journal of heart failure.

[14]  P. Cleary,et al.  The effect of patients' preferences on racial differences in access to renal transplantation. , 1999, The New England journal of medicine.

[15]  M. Harris,et al.  Racial and ethnic differences in health insurance coverage for adults with diabetes. , 1999, Diabetes care.

[16]  W. Aronow,et al.  Diabetes mellitus in older African-Americans, Hispanics, and whites in an academic hospital-based geriatrics practice. , 1999, Coronary artery disease.

[17]  D. Armstrong,et al.  Diabetes-Related Lower-Extremity Amputations Disproportionately Affect Blacks and Mexican Americans , 1999 .

[18]  S. Haffner.  Diabetes, hyperlipidemia, and coronary artery disease. , 1999, The American journal of cardiology.

[19]  L. Suggs,et al.  Culture Counts: Why Current Treatment Models Fail Hispanic Women With Type 2 Diabetes , 1999, The Diabetes educator.

[20]  K. Malmberg,et al.  How to improve the cardiac prognosis for diabetes. , 1999, Diabetes care.

[21]  J. Hermans,et al.  Relationship between blood glucose level and mortality in Type 2 diabetes mellitus: a systematic review , 1999, Diabetic medicine : a journal of the British Diabetic Association.

[22]  D. Himmelstein,et al.  Going bare: trends in health insurance coverage, 1989 through 1996. , 1999, American journal of public health.

[23]  R. Klein,et al.  Is the Risk of Diabetic Retinopathy Greater in Non-Hispanic Blacks and Mexican Americans Than in Non-Hispanic Whites With Type 2 Diabetes?: A U.S. population study , 1998, Diabetes Care.

[24]  E. Larson,et al.  Quality of diabetes care for non-English-speaking patients. A comparative study. , 1998, The Western journal of medicine.

[25]  K. Flegal,et al.  Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994 , 1998, Diabetes Care.

[26]  S. Sedlis,et al.  Racial differences in performance of invasive cardiac procedures in a Department of Veterans Affairs Medical Center. , 1997, Journal of clinical epidemiology.

[27]  R. Glasgow,et al.  Quality of Life and Associated Characteristics in a Large National Sample of Adults With Diabetes , 1997, Diabetes Care.

[28]  M. Harris,et al.  Ambulatory Medical Care for Non-Hispanic Whites, African-Americans, and Mexican-Americans With NIDDM in the U.S , 1997, Diabetes Care.

[29]  R. Holle,et al.  Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: the Munich General Practitioner Project , 1996, Diabetologia.

[30]  J. Pugh,et al.  Non-Insulin-Dependent Diabetes Mellitus in Minorities in the United States , 1996, Annals of Internal Medicine.

[31]  R. Bergman,et al.  The insulin resistance atherosclerosis study (IRAS) objectives, design, and recruitment results. , 1995, Annals of epidemiology.

[32]  Toni Martin,et al.  Physician and Patient Prevention Practices in NIDDM in a Large Urban Managed-Care Organization , 1995, Diabetes Care.

[33]  R. Klein.  Hyperglycemie and Microvascular and Macrovascular Disease in Diabetes , 1995, Diabetes Care.

[34]  Aaron Manson,et al.  Language Concordance as a Determinant of Patient Compliance and Emergency Room Use in Patients with Asthma , 1988, Medical care.